Genomic News and Research

RSS

Study unravels how cancer stem cells use normal genes in abnormal ways

CDK1 is a "normal" protein - its presence drives cells through the cycle of replication. And MHC Class I molecules are "normal" as well - they present bits of proteins on the surfaces of cells for examination by the immune system.

15 Oct 2018

Research shows basophils are key players in lung development

Lungs are vital organs required for the uptake of oxygen in exchange for carbon dioxide. However, the enormous complexity of the respiratory organ is often underestimated and deserves a closer look: A broad range of specialized cells work closely together to ensure the proper functioning of the lung and provide the vital gas exchange.

12 Oct 2018

Scientists use haploid stem cells to produce mice with same-sex parents

In a new study, Chinese researchers were able to produce healthy mouse pups with two mothers. The research involved the use of haploid embryonic stem cells.

12 Oct 2018

Researchers identify effective ketamine dosage levels for patients with treatment-resistant depression

A study led by Massachusetts General Hospital investigators identifies two subanesthetic dosage levels of the anesthetic drug ketamine that appear to provide significant symptom relief to patients with treatment-resistant depression.

11 Oct 2018

Network of doctors identify the cause of 31 new conditions

A network of hundreds of doctors has uncovered the biological characteristics of 31 previously unknown diseases and provided diagnoses for many unsolved cases.

11 Oct 2018

Researchers design modeling system to infer relationships between genes, drugs, and their environment

A team of researchers at the Icahn School of Medicine at Mount Sinai and the University of Washington has designed a modeling system that integrates genomic and temporal information to infer causal relationships between genes, drugs, and their environment, allowing for a more accurate prediction of their interactions over time.

11 Oct 2018

UK Biobank provides wealth of information for further genetic studies

There are 3.2 billion positions on the human genome and it requires a study of huge number of genetic variations in the populations to estimate the associations between genetic disorders and mutations. Two new studies have been published in the journal Nature.

11 Oct 2018

15 promising technologies that could limit global catastrophic biological risks

Strategic investment in 15 promising technologies could help make the world better prepared and equipped to prevent future infectious disease outbreaks from becoming catastrophic events.

10 Oct 2018

New mobile apps may simplify complex genomic and biome data

Spurred by the rapidly expanding use of in-home tests for "omic" - genomic and microbiomic - data for humans, pets, and even homes themselves, university researchers have begun tackling the difficult challenge of making the results interactive and understandable to non-experts.

10 Oct 2018

Celmatix partners with Oncotest-Teva to bring Fertilome test to Israel

Today, Celmatix, a next-generation women's health company, has announced a commercial agreement with Oncotest-Teva Ltd, a subsidiary of Teva Pharmaceutical Industries Ltd. in Israel to bring the Fertilome test, the world's first multigene panel test for a woman's reproductive health and fertility, to the Israeli market.

9 Oct 2018

Personal Genome Diagnostics’ pan-cancer assay being used in new clinical trial

Personal Genome Diagnostics, Inc., a leader in cancer genomics and pioneer in liquid biopsy, today reported that its non-invasive, pan-cancer plasma assay is being used in an important new clinical trial, Nivolumab, Ipilimumab in Patients With Hyper Mutated Cancers Detected in Blood, led by the Cancer Research Institute and Canadian Cancer Trials Group.

9 Oct 2018

New DNA test can predict adult heart attack risk much earlier in life

People at high risk of a heart attack in adulthood could be spotted much earlier in life with a one-off DNA test, according to new research part-funded by the British Heart Foundation and published today in the Journal of the American College of Cardiology.

9 Oct 2018

Veracyte to present data demonstrating potential of Envisia Genomic Classifier to improve ILD diagnosis

Veracyte, Inc. announced the presentation of data demonstrating that the Envisia Genomic Classifier can help physicians more confidently diagnose interstitial lung disease (ILD), including idiopathic pulmonary fibrosis (IPF), without the need for surgery.

8 Oct 2018

Cutting-edge precision medicine spreading from specialist cancer units to community setting

Nearly 1 in 4 patients with advanced cancer, treated at Comprehensive Cancer Care Network centers in the US, are receiving innovative drugs matched to DNA mutations in their tumors.

8 Oct 2018

Researchers find specific place in the genome linked to increased risk of erectile dysfunction

For the first time, a team of researchers has found a specific place in the human genome that raises a person's risk of erectile dysfunction. The discovery is a significant advancement in the understanding of the genetics underlying erectile dysfunction.

8 Oct 2018

Researchers provide new knowledge about retrovirus-host coevolution

Retroviruses have colonized vertebrate hosts for millions of years by inserting their genes into host genomes, enabling their inheritance through generations as endogenous retroviruses.

8 Oct 2018

Neoadjuvant clinical trial of immune checkpoint blockade for melanoma patients yields high response rate

Combination checkpoint blockade before surgery (neoadjuvant therapy) produced a high response rate among patients with high-risk stage 3 melanoma, with nearly half having no sign of disease at surgery, but a high incidence of side effects caused the trial to be closed early.

8 Oct 2018